HelioMystique today announced the availability of its full eight-protocol Bioregulator Dermatology collection under the Opticeuticals Inc. brand. The collection spans three intervention tiers — Corrective, Regenerative, and Restorative — each formulated with a distinct compound class targeting a specific biological mechanism. All protocols are freeze-dried at manufacture and activated at point of use, preserving compound potency through the full Restoration Cycle. The launch positions HelioMystique as the first consumer-facing bioregulator dermatology system in the North American market.